ly 5

LY5 is an inhibitor of STAT3 that acts by inhibiting cell viability, cell migration, and angiogenesis in medulloblastoma cells.

Anti-Mouse Ly-6G Ly-6C Antibody为针对小鼠Ly-6G Ly-6C的IgG2b亚型单克隆抗体，具有抑制作用。

LY 517717 是一种具有口服活性的凝血因子 Xa 抑制剂，具有抗血栓活性，可用于研究静脉血栓栓塞（VTE）。

LY 53857 is a potent and selective antagonist of 5-HT2 serotonin receptor.

LY541850 is a selective orthosteric mGlu2 agonist and mGlu3 antagonist with IC50 values of 0.161 μM and 0.038 μM, respectively.LY 541850 is claimed from human ionotropic and metabotropic glutamate (mGlu) receptors expressed in non-neuronal cells.

Lilly 51641 is used as a MAO inhibitor.

LY 56110 is a novel nonsteroidal aromatase inhibitor.

LY 54761 is a bio-active chemical.

Erteberel (LY500307) 是一种选择性的雌激素受体 β(ERβ) 激动剂，其Ki=1.54 nM，EC50=3.61 nM。具有抗肿瘤作用。

Telaprevir (Incivek) 是一种选择性可逆的HCV NS3-4A 蛋白酶抑制剂，作用于基因 1型 (H 株) NS3 蛋白酶结构域和 NS4A 辅因子肽，Ki 为 7 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。

Fenoprofen (LILLY-5385) 是一种非甾体抗炎化合物，也是黑皮质素受体的变构增强剂，增加 ERK1 2 的激活，抑制生物膜的形成，改变生物膜结构，可用于治疗急性疼痛和慢性关节炎。

LY518674 (LY-674) 是一种高效、选择性的 PPARα 激动剂，对人 PPARα 作用的 EC50 值为 42 nM。LY518674 能降低甘油三酸酯，增加 HDL-C，可用于研究动脉粥样硬化。

LY550410是一种I型TGF-β受体激酶(type ITGF-β receptor kinase)的小分子ATP竞争性抑制剂，含有异芳香环结构，可有效结合至激酶的活性位点。该化合物通过调节TGF-β信号通路来影响基因表达，进而促进细胞生长，有望在癌症研究中发挥作用。

Gly5-Ahx-DM1 是一种转肽酶反应型 Drug-linker,具有创新型高度稳定可降解连接子，DM1 是一种微管蛋白抑制剂，可用于抗体-药物偶联物（ADC）的合成。

LY52 is a matrix metalloproteinase-2 inhibitor. It acts by suppressing tumor invasion and metastasis.

LY503430 is a AMPA receptor potentiator with oral activity. LY503430 has both nootropic and neuroprotective effects, reducing brain damage caused by 6-hydroxydopamine or MPTP.

LY-510929, a peroxisome proliferator-activated receptor (PPAR) agonist, is used potentially for the treatment of hyperlipidaemia, metabolic disorders and type 2 diabetes.

LY593093 is a selective partial orthosteric agonist of M1 muscarinic acetylcholine receptor.

LY-53857 free base is a bioactive chemical.

PNU-EDA-Gly5 is a DNA topoisomerase I inhibitor-based oligo-glycine linker-payload used for the synthesis of antibody-drug conjugates (ADCs). It consists of the DNA topoisomerase I inhibitor PNU-159682 and the linker EDA-Gly5.

LLY-507 是一种有效的、细胞活性的、特异性的蛋白质赖氨酸甲基转移酶 SMYD2 抑制剂。它是一种化学探针，用于解析 SMYD2 在癌症和其他生物过程中的功能。它有抑制 SMYD2 甲基化 p53 肽的能力，IC50小于 15 nM。

LY-580276 is an inhibitor of the type I transforming growth factor beta receptor (TβRI).

Lubabegron, also known as LY591281; LY488756 fumarate, is a veterinary drug used to reduce ammonia emissions from animals and their waste. Ammonia emissions are a concern in agricultural production because of detrimental effects on the environment, human health, and animal health. Lubabegron was approved by the U.S. Food and Drug Administration in 2018 for use in feedlot cattle. Lubabegron is a beta-adrenergic receptor agonist that has the effect of increasing the breakdown of fats and increasing energy expenditure in cells.

Org 24461 is a synaptic and nonsynaptic glycine transporter type-1 inhibitor.